First-in-patient case report of OssDsign Catalyst shows complete spinal fusion 6 months post-surgery

Uppsala, January 4, 2023. OssDsign AB (publ.) today announces that a first-in-patient case report from the clinical study TOP FUSION has been published in Biomedical Journal of Scientific & Technical Research. The peer-reviewed article presents data showing complete spinal fusion 6 months after surgery with the novel nanosynthetic bone graft OssDsign Catalyst.Promising pre-clinical results from the BODEN model have translated into clinical success with early fusion and improvements in both pain and function outcomes.      In the case report, evidence of progression to fusion was